Company intelligence / Profile preview

Barsam Pharmed

Ownership: Private
Development stage: Commercial

Overview

Barsam Pharmed Alborz develops technical knowledge and produces medicines as a knowledge-based pharmaceutical company since 2018. No specific clinical results or programs are detailed in public sources.

Modalities: small moleculesconventional pharmaceuticals
Industry: Biotech

Drug pipeline

2 assets

resburicase

Commercial

Indications: Hyperuricemia

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Barsam Pharmed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Barsam Pharmed.

Explore the full profile